On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology

David B. Chou(Harvard University), Donald E. Ingber(Inspire), Kasiani C. Myers(Immune Deficiency Foundation), Arianna Rech(Loughborough University), Sasan Jalili‐Firoozinezhad(University of Lisbon), Richard Novák(Illinois College), Carl D. Novina(Center for Cancer Research), Douglas Ferguson(AstraZeneca (United States)), Olga K. Weinberg(Boston Children's Hospital), Robert P. Hasserjian(Massachusetts General Hospital), Carlos F. Ng(Harvard University), Viktoras Frismantas, Youngjae Choe(Harvard University), Elizabeth Calamari, Akiko Shimamura(Harvard University), Susan Marquez, Yuka Milton, Lucy R. O’Sullivan, Petar Pop-Damkov(AstraZeneca (United States)), Brooke A. Furlong, Özge Vargel Bölükbaşı(European Molecular Biology Laboratory), Liliana Moreira Teixeira(University of Twente), Oren Levy(Brigham and Women's Hospital), Amanda Jiang(Boston Children's Hospital), Cailin E. Joyce(Washington University in St. Louis), Alexander MacDonald(AstraZeneca (United Kingdom)), Lorna Ewart(AstraZeneca (South Korea)), Rhiannon David(AstraZeneca (United Kingdom)), Rachelle Prantil‐Baun(Harvard University)
Nature Biomedical Engineering
January 27, 2020
Cited by 296


Related Papers